- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/78 - Hydrolases (3.) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
Patent holdings for IPC class C12N 9/78
Total number of patents in this class: 1351
10-year publication summary
34
|
58
|
64
|
90
|
104
|
140
|
183
|
163
|
170
|
81
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Beam Therapeutics Inc. | 229 |
93 |
President and Fellows of Harvard College | 5932 |
87 |
The Broad Institute, Inc. | 1766 |
76 |
Massachusetts Institute of Technology | 9975 |
39 |
The Regents of the University of California | 19780 |
30 |
National University Corporation Kobe University | 513 |
22 |
The General Hospital Corporation | 4695 |
19 |
Spogen Biotech Inc. | 131 |
16 |
Zhejiang University of Technology | 241 |
14 |
PureTech Scientific LLC | 35 |
14 |
BASF SE | 20694 |
13 |
DSM IP Assets B.V. | 5672 |
13 |
Lifeedit Therapeutics, Inc. | 54 |
13 |
Illumina, Inc. | 3254 |
12 |
The Trustees of the University of Pennsylvania | 4289 |
11 |
Pairwise Plants Services, Inc. | 239 |
11 |
Pioneer Hi-Bred International, Inc. | 6461 |
10 |
CJ Cheiljedang Corporation | 3361 |
10 |
Polaris Group | 19 |
10 |
Metagenomi, Inc. | 106 |
10 |
Other owners | 828 |